Navigation Links
Cancer Drug May Boost Risk of Gastrointestinal Perforation
Date:5/25/2009

Review of trials finds Avastin with chemo doubles odds

MONDAY, May 25 (HealthDay News) -- The use of the drug bevacizumab (Avastin) in combination with chemotherapy greatly increases the risk of gastrointestinal perforations in cancer patients, new research has found.

These perforations are potentially life-threatening holes in the wall of the stomach, small intestine or large bowel.

Bevacizumab is designed to slow the growth of tumors by cutting off their blood supply. Concerns have been raised about bevacizumab and gastrointestinal (GI) perforation, but so far no clinical trials have proved a significant association, according to a news release.

In this new study, Dr. Sanjaykumar Hapani and colleagues at Stony Brook University Cancer Center in New York analyzed findings from 17 trials that included a total of 12,294 patients with a variety of solid tumors. The overall incidence of GI perforation among the patients was 0.9 percent (the death rate was 21.7 percent), but patients who took bevacizumab were twice as likely to develop GI perforations.

The researchers also found that the risk of GI perforations among patients taking bevacizumab was dose dependent. Compared to patients who didn't take the drug, those who took 2.5 mg/kg per week of bevacizumab were 61 percent more likely to develop GI perforations, while those who took 5 mg/kg per week of the drug had a 167 percent higher risk.

The risk of GI perforation associated with bevacizumab also varied according to tumor type, the study authors found. Patients with advanced colorectal cancer and renal cell cancer had the highest risk, while those with pancreatic cancer had the lowest risk.

"As bevacizumab is used extensively in routine cancer treatment and in clinical trials, it will be increasingly important to recognize symptoms indicating perforation and intervene promptly to reduce morbidity and fatality," the researchers concluded. "Our study might help to identify a subset of patients receiving bevacizumab at high risk of bevacizumab-associated perforation."

The study appears online and in the June print issue of The Lancet Oncology.

More information

The MedlinePlus Medical Encyclopedia has more about GI perforation.



-- Robert Preidt



SOURCE: The Lancet Oncology, news release, May 24, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Research Sheds Light on Breast Cancer Prognosis
2. Sexually Transmitted HPV Linked to Certain Head & Neck Cancers
3. Breast MRI detects additional unsuspected cancers not seen on mammography or ultrasound
4. Many Black Women Refuse Breast Cancer Treatments
5. Is there any association between COX2 and colon cancer?
6. Low Vitamin D Levels May Initiate Cancer Development
7. Advanced Prostate Cancer Deadlier in Younger Men
8. Younger men with advanced prostate cancer have shorter survival times
9. African-American women with advanced breast cancer often forego vital treatment
10. Key protein may explain the anti-aging and anti-cancer benefits of dietary restriction
11. Viral Genetics Has Option Under Issued Key Patent for Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Drug May Boost Risk of Gastrointestinal Perforation
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name Medical Center ... NY, on December 3rd, to benefit Holy Name Medical Center's programs and services. ... raised over $1 million - the largest event in the Center's history, both ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... Pennsylvania Cable Network (PCN) during the summer of 2016. The program was made ... by the United States Department of Health and Human Services Administration. The ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking attendance at ... for its 33rd Annual Issues & Research Conference, March 2-3, 2017, at ... the conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... a Property owned by an affiliate of Seavest, has won a prestigious national ... Southern Chester County ambulatory care center (ACC) was named “Best New Development, MOBs ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental ... Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related ... and prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... SUWANEE, Ga. , Dec. 9, 2016 /PRNewswire/ ... opening in early December featuring the multi-wavelength Astanza ... Johns Creek clinic specializes in laser tattoo removal, ... as well as ultrasound therapy. Hudes Laser Aesthetica ... Georgia and promises to ...
(Date:12/9/2016)... Fla. , Dec. 9, 2016  Harmar Mobility, LLC announced ... and a member of the Board of Directors. Photo ... ... Mr. Dawson,s ... development of organizations across a variety of industries. He brings to ...
(Date:12/9/2016)... 9, 2016 Research and Markets has announced ... report to their offering. ... The global travel vaccines market to grow at a ... covers the present scenario and the growth prospects of the global ... report considers the revenue generated from the sales of various vaccines ...
Breaking Medicine Technology: